NEI Research News

The inflammatory molecule interleukin-17A (IL-17A) triggers immune cells that in turn reduce IL-17A’s pro-inflammatory activity, according to a new NEI study.

Researchers have shown for the first time that when one optic nerve in the eye is damaged, as in glaucoma, the opposite optic nerve comes to the rescue by sharing its metabolic energy.

A study by a team of Brown University researchers sheds new light on the complementary roles of REM and non-REM sleep in visual perceptual learning.

Researchers have discovered a strategy that can potentially address a major challenge to the current treatment for choroidal neovascularization (CNV), an aggressive form of age-related macular degeneration.

Cerebral (cortical) visual impairment (CVI) is a condition that interferes with the ability of the brain to process information from the eyes, and it has become a leading cause of visual impairment in the U.S.

A new study found that special patented glasses engineered with technically advanced spectral notch filters enhance color vision for those with the most common types of red-green color vision deficiency (“anomalous trichromacy”).

A new study led by researchers at Harvard Medical School and the VA Boston Healthcare System shows that face blindness may arise from deficits beyond visual perception and appears to involve glitches in retrieving various contextual cues from memory.

The key components of electrical connections between light receptors in the eye and the impact of these connections on the early steps of visual signal processing have been identified for the first time.

Researchers have developed a neural network capable of recognizing retinal tissues during the process of their differentiation in a dish.

In experiments in rats and mice, two Johns Hopkins scientists report the successful use of nanoparticles to deliver gene therapy for blinding eye disease.